• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

保留在血管内皮细胞上的野生型和变异型组织型纤溶酶原激活剂的活性。

Activities of wild-type and variant tissue-type plasminogen activators retained on vascular endothelial cells.

作者信息

Suzuki Yuko, Sano Hideto, Tomczyk Martyna, Brzoska Tomasz, Urano Tetsumei

机构信息

Department of Medical Physiology Hamamatsu University School of Medicine Japan.

出版信息

FEBS Open Bio. 2016 Apr 1;6(5):469-76. doi: 10.1002/2211-5463.12057. eCollection 2016 May.

DOI:10.1002/2211-5463.12057
PMID:27419052
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4856425/
Abstract

We reported that tissue-type plasminogen activator (tPA) secreted from vascular endothelial cells (VECs) is retained on the cell surface and effectively evokes both plasminogen activation and fibrin clot dissolution (fibrinolysis) on VECs. Here, to evaluate possibly different behaviors of variants of tPA, we quantitatively assessed these two events separately using green fluorescent protein (GFP)-conjugated tPA in cultured human VECs. The amount of secreted wild-type tPA-GFP correlated well with both the activities of plasminogen activation (r = 0.66) and fibrinolysis (r = -0.93). A variant of tPA-GFP, with a lower affinity to the surface of VECs but higher affinity to fibrin, showed higher fibrinolysis and lower plasminogen activation activity compared to the wild-type.

摘要

我们报道,血管内皮细胞(VECs)分泌的组织型纤溶酶原激活剂(tPA)保留在细胞表面,并能有效引发VECs上的纤溶酶原激活和纤维蛋白凝块溶解(纤维蛋白溶解)。在此,为评估tPA变体可能不同的行为,我们在培养的人VECs中使用绿色荧光蛋白(GFP)偶联的tPA分别对这两个事件进行了定量评估。分泌的野生型tPA-GFP量与纤溶酶原激活活性(r = 0.66)和纤维蛋白溶解活性(r = -0.93)均密切相关。与野生型相比,一种对VECs表面亲和力较低但对纤维蛋白亲和力较高的tPA-GFP变体显示出更高的纤维蛋白溶解活性和更低的纤溶酶原激活活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fee6/4856425/96a0d39b50ad/FEB4-6-469-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fee6/4856425/b184859a5a86/FEB4-6-469-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fee6/4856425/aec905ec2d95/FEB4-6-469-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fee6/4856425/16c220f35d19/FEB4-6-469-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fee6/4856425/0a2e0941bc99/FEB4-6-469-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fee6/4856425/96a0d39b50ad/FEB4-6-469-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fee6/4856425/b184859a5a86/FEB4-6-469-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fee6/4856425/aec905ec2d95/FEB4-6-469-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fee6/4856425/16c220f35d19/FEB4-6-469-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fee6/4856425/0a2e0941bc99/FEB4-6-469-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fee6/4856425/96a0d39b50ad/FEB4-6-469-g005.jpg

相似文献

1
Activities of wild-type and variant tissue-type plasminogen activators retained on vascular endothelial cells.保留在血管内皮细胞上的野生型和变异型组织型纤溶酶原激活剂的活性。
FEBS Open Bio. 2016 Apr 1;6(5):469-76. doi: 10.1002/2211-5463.12057. eCollection 2016 May.
2
TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells.TM5275 延长了分泌型组织型纤溶酶原激活物的保留时间,并增强了血管内皮细胞的纤溶作用。
Thromb Res. 2013 Jul;132(1):100-5. doi: 10.1016/j.thromres.2013.04.003. Epub 2013 Apr 20.
3
Accelerated fibrinolysis and its propagation on vascular endothelial cells by secreted and retained tPA.分泌型和滞留型组织型纤溶酶原激活物介导的加速纤维蛋白溶解及其在血管内皮细胞上的传播。
J Biomed Biotechnol. 2012;2012:208108. doi: 10.1155/2012/208108. Epub 2012 Oct 14.
4
Surface-retained tPA is essential for effective fibrinolysis on vascular endothelial cells.表面保留的 tPA 对于血管内皮细胞的有效纤维蛋白溶解至关重要。
Blood. 2011 Sep 15;118(11):3182-5. doi: 10.1182/blood-2011-05-353912. Epub 2011 Jul 26.
5
Clot lysis mediated by cultured human microvascular endothelial cells.培养的人微血管内皮细胞介导的血栓溶解
Thromb Haemost. 1988 Dec 22;60(3):463-7.
6
Tissue-type plasminogen activator-binding RNA aptamers inhibiting low-density lipoprotein receptor family-mediated internalisation.组织型纤溶酶原激活物结合 RNA 适体抑制 LDL 受体家族介导的内化。
Thromb Haemost. 2015 Jul;114(1):139-49. doi: 10.1160/TH14-08-0686. Epub 2015 Apr 9.
7
Clot penetration and retention by plasminogen activators promote fibrinolysis.纤溶酶原激活物促进血栓穿透和滞留,从而促进纤维蛋白溶解。
Biochem Pharmacol. 2013 Jan 15;85(2):216-22. doi: 10.1016/j.bcp.2012.10.011. Epub 2012 Oct 23.
8
Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation.锌通过减弱纤溶酶原激活和纤溶酶介导的纤维蛋白降解来延迟血凝块溶解。
Thromb Haemost. 2015 Jun;113(6):1278-88. doi: 10.1160/TH14-09-0771. Epub 2015 Mar 19.
9
The effector roles of kringle 1 and kringle 2 in the enzymatic properties of recombinant tissue-type plasminogen activator as revealed by generation of recombinant molecules containing each kringle linked to the protease domain.通过生成包含与蛋白酶结构域相连的每个kringle的重组分子所揭示的kringle 1和kringle 2在重组组织型纤溶酶原激活剂酶学性质中的效应作用。
Arch Biochem Biophys. 1993 Jan;300(1):472-82. doi: 10.1006/abbi.1993.1064.
10
Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis.高度稳定的1型纤溶酶原激活物抑制剂(VLHL PAI-1)可保护纤维蛋白凝块免受组织纤溶酶原激活物介导的纤维蛋白溶解作用。
Int J Mol Med. 2007 Nov;20(5):683-7.

引用本文的文献

1
β-D-Glucan promotes NF-κB activation and ameliorates high-LET carbon-ion irradiation-induced human umbilical vein endothelial cell injury.β-D-葡聚糖促进 NF-κB 激活并减轻高传能线密度碳离子照射诱导的人脐静脉内皮细胞损伤。
Turk J Med Sci. 2023 Sep 21;53(6):1621-1634. doi: 10.55730/1300-0144.5731. eCollection 2023.
2
The Utility and Potential of Mathematical Models in Predicting Fibrinolytic Outcomes.数学模型在预测纤溶结果中的效用与潜力
Curr Opin Biomed Eng. 2021 Dec;20. doi: 10.1016/j.cobme.2021.100337. Epub 2021 Sep 11.
3
Loxoprofen Sodium Alleviates Oxidative Stress and Apoptosis Induced by Angiotensin II in Human Umbilical Vein Endothelial Cells (HUVECs).

本文引用的文献

1
Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion.替奈普酶-组织型纤溶酶原激活剂评估伴已证实闭塞的小面积缺血性脑卒中。
Stroke. 2015 Mar;46(3):769-74. doi: 10.1161/STROKEAHA.114.008504. Epub 2015 Feb 12.
2
Lumenal protein within secretory granules affects fusion pore expansion.分泌颗粒内的管腔蛋白影响融合孔的扩张。
Biophys J. 2014 Jul 1;107(1):26-33. doi: 10.1016/j.bpj.2014.04.064.
3
Protein mobility within secretory granules.分泌颗粒内的蛋白质流动性。
洛索洛芬钠减轻血管紧张素 II 诱导的人脐静脉内皮细胞氧化应激和细胞凋亡。
Drug Des Devel Ther. 2020 Nov 18;14:5087-5096. doi: 10.2147/DDDT.S266175. eCollection 2020.
4
Recognition of Plasminogen Activator Inhibitor Type 1 as the Primary Regulator of Fibrinolysis.认识到纤溶酶原激活物抑制剂1是纤维蛋白溶解的主要调节因子。
Curr Drug Targets. 2019;20(16):1695-1701. doi: 10.2174/1389450120666190715102510.
5
Regulation of plasminogen activation on cell surfaces and fibrin.细胞表面和纤维蛋白上纤溶酶原激活的调节
J Thromb Haemost. 2018 May 20;16(8):1487-97. doi: 10.1111/jth.14157.
Biophys J. 2014 Jul 1;107(1):16-25. doi: 10.1016/j.bpj.2014.04.063.
4
Plasmin-dependent modulation of the blood-brain barrier: a major consideration during tPA-induced thrombolysis?纤溶酶依赖性调节血脑屏障:tPA 诱导溶栓时的主要考虑因素?
J Cereb Blood Flow Metab. 2014 Aug;34(8):1283-96. doi: 10.1038/jcbfm.2014.99. Epub 2014 Jun 4.
5
Human tissue-type plasminogen activator.人组织型纤溶酶原激活物。
Thromb Haemost. 2014 Aug;112(2):243-54. doi: 10.1160/TH13-06-0517. Epub 2014 Apr 10.
6
A randomized trial of tenecteplase versus alteplase for acute ischemic stroke.替奈普酶与阿替普酶治疗急性缺血性脑卒中的随机试验。
N Engl J Med. 2012 Mar 22;366(12):1099-107. doi: 10.1056/NEJMoa1109842.
7
t-PA-specific modulation of a human blood-brain barrier model involves plasmin-mediated activation of the Rho kinase pathway in astrocytes.t-PA 特异性调节人血脑屏障模型涉及星形胶质细胞中纤溶酶介导的 Rho 激酶途径的激活。
Blood. 2012 May 17;119(20):4752-61. doi: 10.1182/blood-2011-07-369512. Epub 2012 Jan 19.
8
Surface-retained tPA is essential for effective fibrinolysis on vascular endothelial cells.表面保留的 tPA 对于血管内皮细胞的有效纤维蛋白溶解至关重要。
Blood. 2011 Sep 15;118(11):3182-5. doi: 10.1182/blood-2011-05-353912. Epub 2011 Jul 26.
9
New insights into the molecular mechanisms of the fibrinolytic system.纤溶系统分子机制的新见解。
J Thromb Haemost. 2009 Jan;7(1):4-13. doi: 10.1111/j.1538-7836.2008.03220.x. Epub 2008 Nov 8.
10
Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic.缺血性脑中的组织型纤溶酶原激活剂:不止是一种溶栓剂。
Trends Neurosci. 2009 Jan;32(1):48-55. doi: 10.1016/j.tins.2008.09.006. Epub 2008 Oct 27.